{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:14:09Z","timestamp":1779257649409,"version":"3.51.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"\n Background<\/jats:title>\n \n Restless Legs Syndrome (RLS) is highly prevalent among adults receiving maintenance hemodialysis and significantly impairs sleep, psychological well-being, and quality of life. While Western pharmacological treatments such as dopaminergic agents, gabapentinoids, and iron therapy are commonly studied, Traditional Chinese Medicine (TCM) is also widely used in clinical practice\u2014particularly for syndromes corresponding to RLS such as\n blood deficiency (Xue Xu)<\/jats:italic>\n ,\n liver\u2013kidney yin deficiency (Gan Shen Bu Zu)<\/jats:italic>\n , and\n blood stasis (Xue Yu)<\/jats:italic>\n . However, the evidence base for TCM pharmacologic interventions in hemodialysis-related RLS remains unclear. This systematic review and meta-analysis evaluated the efficacy and safety of pharmacological therapies, including any available TCM-related pharmacologic treatments, in adults undergoing hemodialysis.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n A comprehensive search of PubMed, EMBASE, CENTRAL, Scopus, Web of Science,\n ClinicalTrials.gov<\/jats:uri>\n , and Chinese-language databases was conducted from inception to January 2025. Eligible studies included randomized, quasi-experimental, and observational studies of pharmacologic therapies\u2014Western medications or TCM-derived pharmaceutical preparations\u2014administered for RLS in adults on hemodialysis. The primary outcome was change in International Restless Legs Scale (IRLS) scores; secondary outcomes included sleep quality, quality of life, dialysis adequacy, and adverse events. Random-effects meta-analyses, subgroup analyses, and GRADE assessments were performed.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Sixteen studies (\n n<\/jats:italic>\n \u202f=\u202f1,324) met inclusion criteria, with nine included in the quantitative analysis. Pharmacologic therapy significantly improved IRLS scores (MD \u20137.84), sleep quality (SMD \u20130.82), and quality of life (SMD 0.48). Gabapentinoids produced the largest symptom reductions, followed by dopaminergic agents and iron therapy. No treatment affected dialysis adequacy. Adverse events increased modestly (RR 1.28), highest with dopaminergic agents. Although the search identified several TCM-related clinical studies, none met criteria for inclusion in the meta-analysis due to lack of standardized RLS diagnosis, inconsistent outcome reporting, or mixed non-pharmacologic interventions. Thus, TCM pharmacologic treatments could not be quantitatively evaluated. Subgroup analyses by drug class demonstrated that gabapentinoids produced the largest reductions in RLS symptom severity, followed by dopaminergic agents and iron therapy. Bar plots illustrate these comparative effects on RLS severity, sleep quality, and quality of life. A heatmap further revealed that dopaminergic agents were associated with the highest frequency of adverse events, particularly nausea, hypotension, and augmentation.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Western pharmacologic agents\u2014particularly gabapentinoids\u2014are effective for managing RLS in hemodialysis patients. Dopaminergic agents are beneficial but limited by higher adverse event risks, while iron therapy offers moderate benefits with good tolerability. Although TCM is widely used for symptom patterns associated with RLS and shows theoretical promise, high-quality, hemodialysis-specific pharmacologic TCM trials are lacking. To support integrated Chinese\u2013Western clinical practice, rigorous future RCTs of standardized TCM formulations are urgently needed. This study provides evidence to guide clinical decision-making and emphasizes the importance of individualizing treatment approaches to balance efficacy and safety for patients undergoing hemodialysis.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fneur.2026.1790771","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:48:14Z","timestamp":1779256094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Juntao","family":"Zhang","sequence":"first","affiliation":[{"name":"Faculty of Chinese Medicine, Macau University of Science and Technology","place":["Avenida Wai Long, Taipa, Macau, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine","place":["Zhuhai, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiebao","family":"Liang","sequence":"additional","affiliation":[{"name":"Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine","place":["Zhuhai, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine","place":["Zhuhai, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"ref2","first-page":"1","article-title":"Epidemiology of restless legs syndrome","volume":"73","author":"Ohayon","year":"2012","journal-title":"J Psychosom Res"},{"key":"ref3","first-page":"2224","article-title":"RLS pathophysiology in renal failure","volume":"25","author":"Trenkwalder","year":"2010","journal-title":"Mov Disord"},{"key":"ref4","first-page":"1113","article-title":"RLS and sleep disturbance","volume":"56","author":"Winkelman","year":"2001","journal-title":"Neurology"},{"key":"ref5","first-page":"697","article-title":"Underdiagnosis of RLS","volume":"9","author":"Picchietti","year":"2008","journal-title":"Sleep Med"},{"key":"ref6","first-page":"204","article-title":"Ropinirole efficacy in RLS","volume":"3","author":"Trenkwalder","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref7","first-page":"53","article-title":"Augmentation with dopaminergic therapy","volume":"30","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med Rev"},{"key":"ref8","first-page":"578","article-title":"Gabapentin in hemodialysis-related RLS: randomized trial","volume":"58","author":"Tai","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"ref9","first-page":"277","article-title":"Pregabalin effectiveness","volume":"30","author":"Collado-Seidel","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"ref10","first-page":"669","article-title":"Intravenous iron for RLS in ESRD","volume":"43","author":"Sloand","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref11","first-page":"21","article-title":"Alternative pharmacological therapies for RLS","volume":"15","author":"Manconi","year":"2011","journal-title":"Sleep Med Rev"},{"key":"ref12","first-page":"140","article-title":"Systematic review of RLS treatments in ESRD","volume":"73","author":"Sevim","year":"2010","journal-title":"Clin Nephrol"},{"key":"ref13","first-page":"282","article-title":"Restless legs syndrome in patients on chronic hemodialysis","volume":"60","author":"Takaki","year":"2003","journal-title":"Clin Nephrol"},{"key":"ref14","first-page":"372","article-title":"Sleep complaints are common in dialysis patients","volume":"28","author":"Walker","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"ref15","first-page":"906","article-title":"Association of restless legs syndrome with outcomes in kidney transplant recipients","volume":"54","author":"Szentkir\u00e1lyi","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref16","first-page":"29","article-title":"Restless legs syndrome pathophysiology and treatment","volume":"38","author":"Trotti","year":"2018","journal-title":"Sleep Med Rev"},{"key":"ref17","first-page":"1686","article-title":"Evidence of increased muscle sympathetic nerve activity in renal patients with restless legs syndrome","volume":"26","author":"Giannaki","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","first-page":"381","article-title":"Restless legs syndrome in hemodialysis patients: associations with sleep quality and fatigue","volume":"12","author":"Giannaki","year":"2011","journal-title":"Sleep Med"},{"key":"ref19","first-page":"123","article-title":"Restless legs syndrome in patients with maintenance hemodialysis: a cross-sectional study","volume":"10","author":"Chu","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"ref20","first-page":"125","article-title":"Treatment of restless legs syndrome with pramipexole in hemodialysis patients: a pilot study","volume":"33","author":"Enomoto","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Role of iron in RLS","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"ref22","first-page":"499","article-title":"Management of restless legs syndrome in hemodialysis patients: a systematic review","volume":"32","author":"Sud","year":"2019","journal-title":"J Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2004.01.007","article-title":"Clinical efficacy of gabapentin for treatment of restless legs syndrome in hemodialysis patients","volume":"43","author":"Sloand","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.5665\/sleep.1988","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder in adults\u2014an update for 2012","volume":"35","author":"Aurora","year":"2012","journal-title":"Sleep"},{"key":"ref25","first-page":"143","article-title":"Diagnosis and treatment of restless legs syndrome","volume":"8","author":"Trenkwalder","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref26","first-page":"1187","article-title":"Considering the role of gabapentinoids in restless legs syndrome","volume":"23","author":"Winkelman","year":"2005","journal-title":"Neurol Clin"},{"key":"ref27","first-page":"90","article-title":"Methadone for refractory restless legs syndrome","volume":"33","author":"Ondo","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"ref28","first-page":"787","article-title":"Prevalence and risk factors of restless legs syndrome in hemodialysis patients","volume":"18","author":"Zhang","year":"2014","journal-title":"Hemodial Int"},{"key":"ref29","first-page":"553","article-title":"Gabapentin therapy for restless legs syndrome in hemodialysis patients: a randomized, placebo-controlled clinical trial","volume":"29","author":"Bilgic","year":"2007","journal-title":"Ren Fail"},{"key":"ref30","first-page":"1","article-title":"Epidemiology, diagnosis, and treatment of restless legs syndrome","volume":"46","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1093\/brain\/awr012","article-title":"Brain iron deficiency in restless legs syndrome","volume":"134","author":"Connor","year":"2011","journal-title":"Brain"},{"key":"ref32","first-page":"45","article-title":"Restless legs syndrome and pruritus are associated with oxidative stress in hemodialysis patients","volume":"55","author":"Akbay","year":"2001","journal-title":"Clin Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Willis-Ekbom disease foundation revised consensus statement","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"ref34","first-page":"104","article-title":"Clinical characteristics of restless legs syndrome","volume":"18","author":"Watanabe","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"ref35","first-page":"331","article-title":"Ferric gluconate is highly efficacious in iron-deficient hemodialysis patients","volume":"72","author":"Coyne","year":"2007","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1081\/JDI-120039823","article-title":"Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients","volume":"26","author":"Micozkadioglu","year":"2004","journal-title":"Ren Fail"},{"key":"ref38","first-page":"569","article-title":"Exercise therapy and restless legs syndrome in ESRD","volume":"11","author":"Sakkas","year":"2010","journal-title":"Sleep Med"},{"key":"ref39","first-page":"84","article-title":"Restless legs syndrome in chronic kidney disease","volume":"3","author":"Sood","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"ref40","first-page":"1","article-title":"Treatment of restless legs syndrome in dialysis patients: study protocol for the DISCO-RLS trial","volume":"21","author":"Collister","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref41","first-page":"403","article-title":"Dopaminergic augmentation of restless legs syndrome","volume":"28","author":"Garcia-Borreguero","year":"2014","journal-title":"CNS Drugs"},{"key":"ref42","first-page":"575","article-title":"Restless legs syndrome in renal failure: prevalence and associated factors","volume":"20","author":"Siddiqui","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"ref43","first-page":"785","article-title":"Sleep disorders in ESRD patients: RLS prevalence","volume":"47","author":"Merlino","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref44","first-page":"514","article-title":"High prevalence of RLS in hemodialysis","volume":"12","author":"Giannaki","year":"2011","journal-title":"Sleep Med"},{"key":"ref45","first-page":"45","article-title":"Sleep quality in hemodialysis patients with RLS","volume":"5","author":"Gigli","year":"2004","journal-title":"Sleep Med"},{"key":"ref46","first-page":"661","article-title":"RLS and cardiovascular risk in ESRD","volume":"30","author":"Lin","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref47","first-page":"290","article-title":"Mortality risk associated with RLS in dialysis","volume":"12","author":"Unruh","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref48","first-page":"1","article-title":"Safety issues of gabapentinoids","volume":"3","author":"Toth","year":"2014","journal-title":"Pain Ther"},{"key":"ref49","first-page":"101456","article-title":"Restless legs syndrome: advances in pathophysiology and treatment","volume":"59","author":"Gao","year":"2021","journal-title":"Sleep Med Rev"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","article-title":"Comorbidities, treatment, and pathophysiology in restless legs syndrome","volume":"17","author":"Trenkwalder","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref51","first-page":"633","article-title":"Restless legs syndrome in hemodialysis patients: prevalence, risk factors, and therapy","volume":"25","author":"Wang","year":"2020","journal-title":"Nephrology (Carlton)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1053\/ajkd.2001.25203","article-title":"Gabapentin for the treatment of restless legs syndrome in hemodialysis patients","volume":"38","author":"Thorp","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1081\/JDI-120039823","article-title":"Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients","volume":"26","author":"Micozkad\u0131o\u011flu","year":"2004","journal-title":"Ren Fail."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/01.wnf.0000135805.33230.73","article-title":"Ropinirole as a treatment of restless legs syndrome in patients on maintenance hemodialysis: an open-label pilot study","volume":"27","author":"Pellecchia","year":"2004","journal-title":"Clin Neuropharmacol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.sleep.2011.11.010","article-title":"Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Sagheb","year":"2012","journal-title":"Sleep Med."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.12861\/jrip.2014.26","article-title":"Efficacy of vitamin C and pramipexole in the treatment of restless legs syndrome in hemodialysis patients","volume":"3","author":"Rafie","year":"2014","journal-title":"J Renal Inj Prev."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e19840","DOI":"10.5812\/ircmj.17(10)2015.19840","article-title":"Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial","volume":"17","author":"Razazian","year":"2015","journal-title":"Iran Red Crescent Med J."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.15171\/npj.2019.10","article-title":"Gabapentin for the treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled, crossover-pilot study","volume":"8","author":"Mousavi Movahed","year":"2018","journal-title":"J Nephropharmacol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4103\/jfmpc.jfmpc_956_19","article-title":"Comparing the effect of pramipexole and gabapentin on the severity of restless legs syndrome in hemodialysis patients","volume":"9","author":"Hajian","year":"2020","journal-title":"J Family Med Prim Care."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12882-020-01931-z","article-title":"DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) trial: a protocol for a randomized crossover trial of ropinirole and gabapentin for the treatment of restless legs syndrome in patients on hemodialysis","volume":"21","author":"Collister","year":"2020","journal-title":"BMC Nephrol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1790771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:48:22Z","timestamp":1779256102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1790771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":60,"alternative-id":["10.3389\/fneur.2026.1790771"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1790771","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1790771"}}